CORE and CooperVision Programs Win 2021 Silver Anvil Awards
McDougall-Led Initiatives Honored Among World’s Best Public Relations Campaigns
McDougall-Led Initiatives Honored Among World’s Best Public Relations Campaigns
ROCHESTER, N.Y., June 11, 2021—The Public Relations Society of America has named five McDougall Communications-led campaigns among the world’s best over the past year, recognizing the agency’s work with five 2021 Silver Anvil honors. Included were programs for the Centre for Ocular Research & Education (CORE) and contact lens innovator CooperVision. The annual ceremony took place last evening via a live stream.
When erroneous reports of contact lens wear risks emerged during the pandemic, a rapid-response campaign from CORE set the record straight with healthcare professionals and consumers, generating more than 5,000 news stories and reaching 55 countries in only 30 days. Those efforts earned two Silver Anvil Awards in the highly competitive COVID-19 Crisis Communications (Healthcare) and COVID-19 Crisis Communications (Non-Profit) categories, and a Silver Anvil Award of Excellence for Global Communications. [VIEW THE CORE CASE SYNOPSIS HERE]
A related, highly-targeted program for CORE regarding the same issue also earned a Silver Anvil Award of Excellence in the Marketing on a Shoestring category. Other nominees across CORE’s categories include Carnival Corporation, the Alaska SeaLife Center, Meals on Wheels, Xavier University of Louisiana, and Johnson & Johnson Medical Devices Companies.
The United States launch of CooperVision MiSight® 1 day, the first FDA-approved* soft contact lens designed for myopia control in children aged 8-12 at the initiation of treatment,[1,2] was instrumental in building the category and helping eye care professionals embrace the breakthrough technology. The industry-focused campaign earned a Silver Anvil Award in the Marketing Business-to-Business Products category. A quantum computing program from Honeywell was the category’s Award of Excellence honoree. [VIEW THE COOPERVISION CASE SYNOPSIS HERE]
CooperVision’s companion MiSight 1 day consumer launch with partner agency EvolveMKD also earned a Silver Anvil Award in the Marketing Consumer Products (Packaged Goods) category.
“We’re privileged to work with organizations such as CooperVision and CORE who place a high value on strategy-centered campaigns. Clear, accurate and distinctive communications are more critical than ever to break through the noise. Doing so in a year unlike any other—battling a global misinformation crisis on one front while launching a breakthrough healthcare product on another—required remarkable efforts across the board. I could not be prouder of all the people behind these programs,” said Mike McDougall, APR, Fellow PRSA, the firm’s founder and president.
Since 1944, the Silver Anvils have been presented to organizations that successfully address challenging issues with exemplary professional skill, creativity, and resourcefulness. They are widely considered the Oscars of the profession, owing to their stringent judging process and candidates from around the world. McDougall Communications won PRSA Silver Anvil Awards in 2015 and 2018, with members of the firm having earned another 10 Anvils and Awards of Excellence while in prior roles.
McDougall Communications (mcdougallpr.com), founded in 2011, is focused on helping clients across the Americas, Europe and Asia-Pacific meet their business objectives through a range of communications services, including strategic planning, media and influencer relations, reputation and crisis counsel, and social media management. It is the most senior standalone public relations and reputation management firm in Upstate New York and is regularly looked to as an influencer shaping global communications advancements.
# # #
*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
1. Compared to a single vision 1 day lens over a 3 year period.
2. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-67.
When erroneous reports of contact lens wear risks emerged during the pandemic, a rapid-response campaign from CORE set the record straight with healthcare professionals and consumers, generating more than 5,000 news stories and reaching 55 countries in only 30 days. Those efforts earned two Silver Anvil Awards in the highly competitive COVID-19 Crisis Communications (Healthcare) and COVID-19 Crisis Communications (Non-Profit) categories, and a Silver Anvil Award of Excellence for Global Communications. [VIEW THE CORE CASE SYNOPSIS HERE]
A related, highly-targeted program for CORE regarding the same issue also earned a Silver Anvil Award of Excellence in the Marketing on a Shoestring category. Other nominees across CORE’s categories include Carnival Corporation, the Alaska SeaLife Center, Meals on Wheels, Xavier University of Louisiana, and Johnson & Johnson Medical Devices Companies.
The United States launch of CooperVision MiSight® 1 day, the first FDA-approved* soft contact lens designed for myopia control in children aged 8-12 at the initiation of treatment,[1,2] was instrumental in building the category and helping eye care professionals embrace the breakthrough technology. The industry-focused campaign earned a Silver Anvil Award in the Marketing Business-to-Business Products category. A quantum computing program from Honeywell was the category’s Award of Excellence honoree. [VIEW THE COOPERVISION CASE SYNOPSIS HERE]
CooperVision’s companion MiSight 1 day consumer launch with partner agency EvolveMKD also earned a Silver Anvil Award in the Marketing Consumer Products (Packaged Goods) category.
“We’re privileged to work with organizations such as CooperVision and CORE who place a high value on strategy-centered campaigns. Clear, accurate and distinctive communications are more critical than ever to break through the noise. Doing so in a year unlike any other—battling a global misinformation crisis on one front while launching a breakthrough healthcare product on another—required remarkable efforts across the board. I could not be prouder of all the people behind these programs,” said Mike McDougall, APR, Fellow PRSA, the firm’s founder and president.
Since 1944, the Silver Anvils have been presented to organizations that successfully address challenging issues with exemplary professional skill, creativity, and resourcefulness. They are widely considered the Oscars of the profession, owing to their stringent judging process and candidates from around the world. McDougall Communications won PRSA Silver Anvil Awards in 2015 and 2018, with members of the firm having earned another 10 Anvils and Awards of Excellence while in prior roles.
McDougall Communications (mcdougallpr.com), founded in 2011, is focused on helping clients across the Americas, Europe and Asia-Pacific meet their business objectives through a range of communications services, including strategic planning, media and influencer relations, reputation and crisis counsel, and social media management. It is the most senior standalone public relations and reputation management firm in Upstate New York and is regularly looked to as an influencer shaping global communications advancements.
# # #
*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
1. Compared to a single vision 1 day lens over a 3 year period.
2. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-67.